GE HealthCare is a leading global medical technology and digital solutions innovator, dedicated to providing integrated solutions that enhance hospital efficiency, clinician effectiveness, and patient health. Their extensive portfolio includes advanced imaging technologies such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and molecular imaging, along with patient monitoring systems and digital health solutions. Committed to precision care, GE HealthCare invests approximately $1 billion annually in research and development, ensuring continuous innovation. With a worldwide presence, the company serves healthcare providers across various regions, addressing diverse medical needs.
This system offers new capabilities for both clinical imaging and neuroscience with the potential to aid in the detection of neurological, oncological, and psychiatric conditions.
Collaboration will leverage GE HealthCare’s legacy and scale of imaging innovation and RadNet’s DeepHealth AI-powered clinical and workflow solutions to further the innovation, commercialization, and adoption of AI in imaging.
Versana Premier offers an advanced imaging platform designed to deliver exceptional image quality with its next-generation image engine, first-class display technology, and high-quality probes.
In collaboration with Blackford, the new AI-enabled offerings help radiologists with their workload which could help lead to quicker diagnosis and treatment for patients.
Venue Sprint™, the latest Venue family solution, offers maximum portability and advanced capabilities for high-quality scanning and support at the point of care.
CE mark of these next-generation cardiac imaging systems will further enable connected care along the cardiology patient journey and provide clinicians with the tools to deliver more efficient and timely care.
GE HealthCare selects AWS as its strategic cloud provider to deliver entirely new, purpose-built foundation models designed to fast-track the development of innovative healthcare applications.
Guidance from preoperative magnetic resonance imaging (MRI) helps clinicians deliver more precise high dose-rate (HDR) prostate brachytherapy treatments.